Phenobarbital for Severe Alcohol Withdrawal Syndrome: A Multicenter Retrospective Cohort Study.
Phenobarbital for Severe Alcohol Withdrawal Syndrome: A Multicenter Retrospective Cohort Study.
复制标题
苯巴比妥治疗严重戒酒综合症：多中心回顾性队列研究。
DOI：
10.1164/rccm.202203-0466le
复制
发表时间：
2022
影响因子：
24.7
通讯作者：
Walkey,AllanJ
中科院分区：
文献类型：
--
作者：
Bosch,NicholasA;Law,AnicaC;Walkey,AllanJ
方法我们使用2016-2020年Premier医疗保健数据库（5）（约20%的美国住院患者）识别SAWS患者：在入院第1天入住ICU的成年人，国际疾病分类第十版主要或酒精戒断的入院诊断代码，并接受苯二氮卓类药物或苯巴比妥治疗。我们排除了在第1天接受IMV的患者，从外院转移的患者，以及入院的合格患者< 25例的患者（6）。
MethodsWe used the Premier Healthcare Database, 2016–2020 (5)(∼ 20% of US hospitalizations) to identify patients with SAWS: adults admitted to an ICU on Day 1 of admission with International Classification of Diseases, Tenth Revision primary or admitting diagnosis codes for alcohol withdrawal and who received benzodiazepines or phenobarbital. We excluded patients who received IMV on Day 1, transferred from outside hospitals, and admitted to hospitals with< 25 eligible patients (6).